...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of 'high'.
【24h】

Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of 'high'.

机译:静脉注射哌醋甲酯阻断纹状体多巴胺转运蛋白不足以引起自我报告“高”。

获取原文
获取原文并翻译 | 示例

摘要

The reinforcing effects of cocaine and methylphenidate have been linked to their ability to block dopamine transporters (DAT). Using positron emission tomography (PET), we previously showed that intravenous cocaine induced a significant level of DAT blockade, which was associated with the intensity for self-reports of "high" in cocaine abusers. In this study, we measured DAT occupancies after intravenous methylphenidate and assessed whether they also were associated with the "high". Occupation of DAT by intravenous MP was measured with PET using [11C]cocaine, as a DAT ligand, in eight normal control subjects tested with different methylphenidate doses. The ratio of the distribution volume of [11C]cocaine in striatum to that in cerebellum, which corresponds to Bmax/Kd + 1, was used as measure of DAT availability. In parallel, self-reports of "high" were measured. Methylphenidate produced a dose-dependent blockade of DAT with an estimated ED50 of 0.075 mg/kg. DAT occupancies were significantly correlated with the "high" (p <.03). However, four of the eight subjects, despite having significant levels of DAT blockade, did not perceive the "high". Methylphenidate is as effective as cocaine in blocking DAT in the human brain (cocaine ED50 = 0.13 mg/kg), and DAT blockade, as for cocaine, was also associated with the "high". However, the fact that there were subjects who despite significant DAT blockade did not experience the "high" suggests that DAT blockade, although necessary, is not sufficient to produce the "high".
机译:可卡因和哌醋甲酯的增强作用与它们阻断多巴胺转运蛋白(DAT)的能力有关。使用正电子发射断层扫描(PET),我们先前显示静脉注射可卡因可引起显着水平的DAT阻断,这与可卡因滥用者自我报告的“高”强度有关。在这项研究中,我们测量了静脉注射哌醋甲酯后DAT的占用率,并评估它们是否也与“高”相关。在[8]的正常对照组中,使用[11C]可卡因作为DAT配体,通过PET测量了静脉MP对DAT的占用,并用不同的哌醋甲酯剂量进行了测试。纹状体中[11C]可卡因与小脑中的可卡因分布量之比(相当于Bmax / Kd +1)被用作DAT可用性的量度。同时,测量了“高”的自我报告。哌醋甲酯产生剂量依赖性的DAT阻断,估计ED50为0.075 mg / kg。 DAT占用率与“高”显着相关(p <.03)。然而,尽管有严重的DAT阻断,但八名受试者中有四名没有感觉到“高”。哌醋甲酯与可卡因一样有效地阻断人脑中的DAT(可卡因ED50 = 0.13 mg / kg),而DAT的阻断作用与可卡因一样也与“高”相关。但是,有些受试者尽管进行了DAT显着封锁,但仍未经历“高”反应,这表明DAT阻断尽管是必要的,但不足以产生“高”反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号